WADE JEFFREY L 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
WADE JEFFREY L
EVP, Gen. Counsel
Transactions
- Exercise/Conversion
Common Stock
2023-02-28+11,176→ 235,323 total - Exercise/Conversion
Common Stock
2023-02-28+30,467→ 224,147 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−37,273→ 74,547 total→ Common Stock (37,273 underlying) - Exercise/Conversion
Common Stock
2023-02-28+37,273→ 272,596 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−30,467→ 0 total→ Common Stock (30,467 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−30,255$65,653→ 242,341 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−11,176→ 11,177 total→ Common Stock (11,176 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.